1.Evaluation of Hypercoagulable Status after Off-Pump Coronary Artery Bypass Using Platelet-Derived Microparticles
Hidetoshi Yamauchi ; Masamichi Ito ; Toru Watanabe ; Hiroyuki Satoh ; Yoshiro Matsui
Japanese Journal of Cardiovascular Surgery 2007;36(3):121-126
Thromboembolic events after cardiac surgery, including ischemic strokes, can be devastating complications, however only a few studies manifest the platelet activation and coagulation state after off-pump coronary artery bypass (OPCAB). Platelet-derived microparticles (PMP) are observed as released vesicles from platelets following platelet activation, and are believed to play a role in some clinical diseases because of their procoagulant activity. The aim of the present study was to evaluate the hypercoagulant state after OPCAB using PMP and other indices. Data were obtained from 15 patients (aged 69±7 years; only men) undergoing elective OPCAB surgery. One hundred milligrams of aspirin were used as postoperative antiplatelet drugs. Preoperative risk factors, operation time, postoperative hospital stay, transfusion and blood samples of CBC, PMP, βTG, PF 4, platelet aggregation, FDP, D-dimer and TAT of pre- and postoperative days (POD) 3 and 7 were studied. There was no difference between the PMP level with or without risk factor. The PMP levels of POD 3 and 7 were significantly higher compared to the preoperative levels (pre-op, POD 3, 7:9.1±5.1, 15.2±10.3, 28.4±24.5/104plt respectively, p<0.05). The levels of FDP, D-dimer and TAT rose significantly on POD 3 and 7 and significantly correlated with the PMP levels. Beta TG, PF 4 and platelet aggregation did not change after OPCAB surgery, and no correlation was found with the PMP levels. Elevated levels of PMP, TAT, FDP and D-dimer persisted until POD 7 and suggested not only platelet activation, but also activation of the coagulation and fibrinolytic system. The findings suggest that 100mg of aspirin may not be adequate for the inhibition of platelet activation after OPCAB surgery.
2.Creating a list of psycho-social problems and solutions for patients with pancreatic cancer by applying the social problem-solving process
Mariko Shiozaki ; Atsuko Sakami ; Takayuki Satoh ; Hidetoshi Eguchi ; Masahiro Tanemura ; Toru Kitagawa ; Toshinori Ito ; Kei Hirai
Palliative Care Research 2015;10(3):186-193
Purpose: The aim of this study was to create a list of psycho-social problems and solutions for patients with pancreatic cancer by applying the social problem-solving process. Methods: A semi-structured interview of approximately 1 hour was conducted on two occasions. The participants were 17 patients with pancreatic cancer. Results: Psycho-social problems were divided into two themes: “facing the future uncertainty” and “facing the effects of treatment received”. A list of problems and solutions was created for each problem theme. Realistic goals for “facing the future uncertainty” were ‘maintaining this living condition (n=7)’, ‘preparing for changes to the environment (n=5)’, ‘keeping a sense of control over my own life (n=5)’ and ‘dealing with anxiety (n=3)’. Realistic goals for “facing the effects of treatment received” were ‘restoring the self of pre-illness(n=2)’. Conclusion: For seemingly unsolvable problems, patients can formulate realistic goals that they want to have clarified, and then the problems can be recaptured as solvable problems.
3.A Rare Case of Intramyocardial Lipoma
Kazuhiko Ishimaru ; Hiroto Iwasaki ; Toru Ishizaka ; Hisashi Satoh ; Takashi Shintani ; Takashi Shibuya
Japanese Journal of Cardiovascular Surgery 2010;39(6):325-327
A 72-year-old woman was admitted with a sensation of compression and shortness of breath. A mass was detected in the right atrium (RA) by transthoracic echocardiography. Preoperative chest computed tomography showed an RA tumor measuring 30×24 mm in the lateral wall. We performed resection under the cardiopulmonary bypass. Histopathological examination confirmed that this tumor was a lipoma.
4.Pulmonary hypertension: a review of current clinical practice.
Chinese Journal of Cardiology 2014;42(6):450-452
This short review illustrates current epidemiology, diagnosis and treatment of pulmonary hypertension. In the first part, classification, definition and prevalence of pulmonary hypertension (PH) are explained. According to recent reports, overall PH prevalence was 0.3% to 6.0% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) constituting far less proportion of 10 to 50 per 1 million people. In diagnosis, flow of diagnosis of PH, differential diagnosis of PH and how to determine the severity of PH are explained including recent development of magnetic resonance imaging (MRI) and gene abnormality study on BMPRII. In treatment, newly-developed pulmonary vasodilators are shown as well as how to combine them in PAH, and in CTEPH treatment the drugs, operation and catheter therapy including our experience are demonstrated.
Humans
;
Hypertension, Pulmonary
;
diagnosis
;
therapy
5.Current practice for pulmonary hypertension.
Chinese Medical Journal 2014;127(19):3491-3495
OBJECTIVETo investigate the current practice of pulmonary hypertension including current epidemiology, diagnosis and treatment.
DATA SOURCESThe review was based on data obtained from the published articles and guidelines.
STUDY SELECTIONArticles with high level of evidence or current best evidence in each issue were selected to be reviewed.
RESULTSOverall prevalence of pulmonary hypertension was 0.3% to 6% with left heart disease occupying the most proportion, followed by pulmonary disease, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. In diagnosis, a flow diagram of diagnosis of pulmonary hypertension, differential diagnosis of pulmonary hypertension and how to determine the severity of pulmonary hypertension are explained including recent development of magnetic resonance imaging and gene abnormality study on bone morphogenetic protein receptor II. In treatment, newly-developed pulmonary vasodilators and the way to use them are shown to treat pulmonary hypertension.
CONCLUSIONSafer and more effective treatment algorithm and basic researches and clinical trials are warranted to be explored.
Humans ; Hypertension, Pulmonary ; diagnosis ; drug therapy ; epidemiology
6.Coronary Artery Bypass Grafting in the Presence of Atherosclerotic Lesions in the Ascending Aorta.
Tadashi Isomura ; Toru Satoh ; Nobuhiko Hayashida ; Hiroshi Maruyama ; Kouichi Hisatomi ; Tatsuya Higashi ; Kouichi Arinaga ; Ikutaroh Akasu ; Kenichi Kosuga ; Shigeaki Aoyagi
Japanese Journal of Cardiovascular Surgery 1997;26(2):77-82
The results and surgical techniques were studied in 59 patients who had atherosclerotic lesions in the ascending aorta. Arterial grafting (AG) and sequential grafting for coronary artery bypass grafting (CABG) was used in as many as possible cases and the number of distal anastomoses with AG was 1.3/patient (internal thoracic artery (ITA), 56 anastomoses for 50 patients; gastroepiploic artery (GEA), 17; and inferior epigastric artery, 3). Calcification in the ascending aorta was noted in 26 patients and arterial cannulation was performed via the right axillary artery in 4 patients. Saphenous vein grafts were used for 51 patients and 30 of them required aortic reconstruction for proximal anastomosis. There were 2 hospital deaths (non-cardiac) and no neurological complications. It is difficult to perform CABG in the presence of atherosclerosis in the ascending aorta. However, the right axillary artery cannulation as the site of arterial cannulation and the use of sequential grafting, using ITA and GEA as the pedicled arterial conduits are useful to accomplish CABG in such patients. Neurological complication seems to be manufactured at a minimal level by cautious operative techniques.
7.A Case of Aortic Stenosis Secondary to Bicuspid Aortic Valve Associated with Klippel-Feil Syndrome Treated by Aortic Valve Replacement.
Shigeru Ohki ; Susumu Ishikawa ; Akio Ohtaki ; Toru Takahashi ; Yasushi Satoh ; Tetsuya Koyano ; Toshiharu Yamagishi ; Takashi Ogino ; Satoshi Ohki ; Yasuo Morishita
Japanese Journal of Cardiovascular Surgery 1997;26(3):200-203
A 52-year-old male was diagnosed as having aortic stenosis secondary to a bicuspid aortic valve associated with Klippel-Feil syndrome. Aortic valve replacement was successfully performed without any problems in the surgical or anesthesiological management. Only five such cases including ours, who underwent cardiac surgery have been reported. It is possible to perform cardiac surgery for patients with Klippel-Feil syndrome of their cardiac function can be well preserved.